BD Veo Insulin Syringes with BD Ultra-Fine needles by Becton Dickinson are designed for maximum comfort, accuracy, and patient confidence. Featuring the shortest BD Ultra-Fine needle, BD Veo insulin syringes reduce the risk of intramuscular injections by approximately 8 times, making them a preferred choice among patients and healthcare professionals alike.
BD Veo insulin syringes offer smooth flow, accurate dosing, and ease of use for patients who rely on daily insulin therapy.
BD is now embecta
BD (Becton Dickinson) has officially rebranded its Diabetes Care division as embecta. While the name and packaging may look different, rest assured that the products themselves have not changed. They are manufactured in the same facilities, using the same materials, and follow the same rigorous quality standards you’ve come to trust from BD. The part numbers (NDC/HRI) remain valid and now include NRC codes for updated pharmacy systems.
Features and Benefits
- Minimizes risk of intramuscular injection and hypoglycemia
- Less intimidating appearance for improved patient compliance
- Surgical-grade stainless steel construction
- 3-bevel cut tip for smoother, sharper injection
- Thin wall cannula for improved insulin flow
- Clear polypropylene hub and 2 mL graduation markings
- Gamma radiation sterilized
- Not made with natural rubber latex
